Back to Search Start Over

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Authors :
Das, Deepika Sharma
Ravillah, Durgadevi
Ray, Arghya
Song, Yan
Munshi, Nikhil C.
Richardson, Paul G.
Chauhan, Dharminder
Anderson, Kenneth C.
Source :
Blood; December 2014, Vol. 124 Issue: 21 p3439-3439, 1p
Publication Year :
2014

Abstract

Munshi: Ocopep: Consultancy, Equity Ownership, Patents & Royalties; Sanofi-Aventis: Consultancy; Janssen: Consultancy; Onyx: Consultancy; Celgene: Consultancy. Richardson:Oncopeptides AB: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; Millennium: Membership on an entity's Board of Directors or advisory committees. Chauhan:Triphase Accelerator: Consultancy. Anderson:Celgene: Consultancy; Millenium: Consultancy; Onyx: Consultancy; Gilead: Consultancy; Sanofi Aventis: Consultancy; BMS: Consultancy; Oncopep/Acetylon: Equity Ownership.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
124
Issue :
21
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53029120
Full Text :
https://doi.org/10.1182/blood.V124.21.3439.3439